Business Standard

Serum Institute applies for EU nod through drugmaker AstraZeneca

SII Chief Executive Officer Adar Poonawalla said on Mon­day he had taken it up at the "highest levels".

Adar Poonawalla, CEO, Serum Institute
Premium

Adar Poonawalla, CEO, Serum Institute of India

Sohini Das Mumbai
Amid concern around visits to Europe by individuals who to­ok the jab of Serum Institute of India (SII), company sources have said SII has applied for marketing auth­ori­sation before the European Medicine Age­ncy (EMA) thro­ugh British drug­maker Astra­Zeneca, its vaccine partner.

So far, 287 million Covis­hield shots, single and double, have been given in India, and the company has exported close to 70 million doses.

SII Chief Executive Officer Adar Poonawalla said on Mon­day he had taken it up at the “highest levels”. If Euro­pean Union (EU) restriction on Covishield continues, at least a few hundred million people would face challenges entering

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in